Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Kneat.com Inc T.KSI

Alternate Symbol(s):  KSIOF

kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a configurable, off-the-shelf application focused on validation lifecycle management and testing primarily within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become efficient and compliant with an automated process that has traditionally been manual, inefficient and paper-based. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, cold chain validation, and others.


TSX:KSI - Post by User

Post by Possibleidiot01on Aug 26, 2022 4:07pm
314 Views
Post# 34923452

Michael hakes - BNN - Top Pick

Michael hakes - BNN - Top Pick

Kneat (KSI TSX) 

Most Recent buy: Feb 2022. $3.00 

Kneat is a small software company based in Ireland and listed on the TSX. The market cap is about $230 million.  

Its expertise is within the validation and compliance processes of the life science industry. Its software has been shown to dramatically improve cycle times and reduce process steps and site acceptance testing times. 

Today, Kneat’s customer list includes eight of the world’s top 10 pharma companies and 62 total contracted customers and the largest pipeline in its history.  

They are beginning to scale at several of its large pharma clients and this should continue for some time.


<< Previous
Bullboard Posts
Next >>